SCHEMBL695773

SCHEMBL695773

CC1=CC(C)(C)C(C)CC1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
CNR2 P34972 1/20 0.31
KMT2A Q03164 1/20 0.31
PPARA Q07869 1/20 0.31
PTAFR P25105 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19120956 0.77
SCHEMBL10802296 0.74 STAT3 (0.35) MEN1CNR2KMT2APPARA
SCHEMBL14351154 0.70
SCHEMBL10861624 0.70 TRPA1 (0.36)
SCHEMBL11444142 0.67
SCHEMBL8336298 0.66 MEN1 (0.31) MEN1CNR2KMT2APPARA
SCHEMBL8338836 0.64 MEN1 (0.33) MEN1CNR2KMT2APPARA
SCHEMBL3103528 0.62
SCHEMBL23449274 0.60
SCHEMBL5161922 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8003094-A None JP disclosed
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor FIRMENICH SA (CH) 2023-09-05 US disclosed
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 US disclosed
EP-2421815-B1 ACETALS AS PERFUMING INGREDIENTS FIRMENICH & CIE (CH) 2013-05-01 EP disclosed
US-8236749-B2 Acetals as perfuming ingredients FIRMENICH SA (CH) 2012-08-07 US disclosed
EP-2421815-A1 ACETALS AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2012-02-29 EP disclosed
US-20120010114-A1 ACETALS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-01-12 US disclosed
WO-2010122451-A1 ACETALS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2010-10-28 WO disclosed
JP-H083094-A CYCLOHEXENE DERIVATIVE T HASEGAWA CO LTD 1996-01-09 JP disclosed
EP-0210391-A1 Process for the preparation of cyclic compounds L. GIVAUDAN & CIE Société Anonyme (CH) 1987-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744785-B2 Use of volatile compositions to limit or eliminate the perception of malodor TAS2R8, TRPA1, TAS2R10 MEN1 3715/4885CNR2 106/4885KMT2A 4388/4885
US-20120010114-A1 ACETALS AS PERFUMING INGREDIENTS CBR1, CBR3, C9 MEN1 3017/4885CNR2 197/4885KMT2A 1558/4885
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 MEN1 3715/4885CNR2 106/4885KMT2A 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.